Excelsior Medical : The Board of Directors release the prohibition on managers from participation in competition businesses.

 The Board of Directors release the prohibition on
managers from participation in competition businesses.

1.Date of the board of directors resolution:2022/08/04
2.Name and title of the managerial officer with permission to engage in
  competitive conduct:Chou Cheng-Hsiao，Corporate Governance Officer.
3.Items of competitive conduct in which the officer is permitted to engage:
Acting in the business of the same or similar nature of
a company as thatof the company.
4.Period of permission to engage in the competitive conduct:
For the duration of being employed as a manager of the
Company.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 32 of the Company Act):
All directors present at the meeting pass unanimously.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the managerial officer
(if it is not the operator of a mainland China area enterprise, please enter
"N/A" below):
Chou Cheng-Hsiao，Corporate Governance Officer.
7.Company name of the mainland China area enterprise and the officer's
position in the enterprise:
Supervisor of SinoExcelsior Investment Incorporation.
8.Address of the mainland China area enterprise:
SinoExcelsior Investment Incorporation address:
Room 301-2, No.1089, Kang Ning Lu, Shanghai Shi, China.
9.Operations of the mainland China area enterprise:
enterprise management consulting, business information
consulting,technical consulting and technical services
in the professional field of medical technology (except
for the development and application of human stem cells,
gene diagnosis and treatment technology), and wholesale
of cosmetics , import and export, beauty-related shop,
hair-related shop(limited to branch operations).
10.Impact on the company's finance and business:None.
11.If the managerial officer has invested in the mainland China area
enterprise, the monetary amount of the investment and the officer's
shareholding ratio:None.
12.Any other matters that need to be specified:None.